AbstractAnimal models and human studies of allogeneic hematopoietic cell transplantation (HCT) demonstrate that immunologic nonidentity between donor and recipient is responsible for a graft versus leukemia (GVL) effect that contributes to complete tumor eradication. A variety of immune cells have been implicated in the GVL effect including NK cells, B cells, and CD4+ and CD8+ T cells that recognize minor histocompatibility (H) or leukemia-associated antigens. Here we discuss strategies for employing T cells specific for minor H antigens to augment the GVL effect
Minor histocompatibility antigens (mHAg) composed of peptides presented by HLA molecules can cause i...
In mice, as in humans, lethal graft-versus-host disease (GVHD) with skin involvement often occurs in...
T cells specific for hematopoietic system restricted minor Histocompatibility (H) antigens target no...
AbstractAnimal models and human studies of allogeneic hematopoietic cell transplantation (HCT) demon...
The graft-versus-leukemia (GVL) effect of HLA-identical allogeneic stem cell transplantation is main...
In allogeneic hematopoietic stem cell transplantation (alloHCT), donor-derived T cells that recogniz...
MHC-matched hemopoietic stem cell transplantation is commonly used for the treatment of some forms o...
The effect of minor H antigen mismatching on the occurrence of graft-versus-host disease (GvHD) and ...
In allo-SCT, an immune reaction between donor T cells and recipient histocompatibility antigens (mHa...
Allogeneic stem cell transplantation (SCT) is the treatment of choice for many hematological maligna...
AbstractIn allogeneic hematopoietic stem cell transplantation (AHSCT) graft-versus-host disease (GVH...
Clinical studies indicated an enhanced antileukemic effect of allogeneic bone marrow transplantation...
AbstractThe effect of minor H antigen mismatching on the occurrence of graft-versus-host disease (Gv...
Donor T cells contribute to the success of allogeneic hematopoietic stem cell transplantation (alloS...
AbstractAllogeneic HSCT is the most reliable, robust, and effective cell-based biotherapy currently ...
Minor histocompatibility antigens (mHAg) composed of peptides presented by HLA molecules can cause i...
In mice, as in humans, lethal graft-versus-host disease (GVHD) with skin involvement often occurs in...
T cells specific for hematopoietic system restricted minor Histocompatibility (H) antigens target no...
AbstractAnimal models and human studies of allogeneic hematopoietic cell transplantation (HCT) demon...
The graft-versus-leukemia (GVL) effect of HLA-identical allogeneic stem cell transplantation is main...
In allogeneic hematopoietic stem cell transplantation (alloHCT), donor-derived T cells that recogniz...
MHC-matched hemopoietic stem cell transplantation is commonly used for the treatment of some forms o...
The effect of minor H antigen mismatching on the occurrence of graft-versus-host disease (GvHD) and ...
In allo-SCT, an immune reaction between donor T cells and recipient histocompatibility antigens (mHa...
Allogeneic stem cell transplantation (SCT) is the treatment of choice for many hematological maligna...
AbstractIn allogeneic hematopoietic stem cell transplantation (AHSCT) graft-versus-host disease (GVH...
Clinical studies indicated an enhanced antileukemic effect of allogeneic bone marrow transplantation...
AbstractThe effect of minor H antigen mismatching on the occurrence of graft-versus-host disease (Gv...
Donor T cells contribute to the success of allogeneic hematopoietic stem cell transplantation (alloS...
AbstractAllogeneic HSCT is the most reliable, robust, and effective cell-based biotherapy currently ...
Minor histocompatibility antigens (mHAg) composed of peptides presented by HLA molecules can cause i...
In mice, as in humans, lethal graft-versus-host disease (GVHD) with skin involvement often occurs in...
T cells specific for hematopoietic system restricted minor Histocompatibility (H) antigens target no...